Gainers
- Bright Minds Biosciences Inc. (NASDAQ:DRUG) shares jumped 72.8% to close at $2.16 on Monday as the stock continued to see momentum despite the company last week announcing it is not aware of any developments that would explain the recent surge.
- AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) surged 66% to close at $0.3561 after declining 8% on Friday. Anpac Bio-Medical Science recently named Yuyang Cui as Co-Chairman and co-CEO.
- Summit Therapeutics Inc. (NASDAQ:SMMT) jumped 48.2% to close at $1.63. The company's Co-CEO's recently purchased over 100 million shares of stock in the company.
- Minerva Neurosciences, Inc. (NASDAQ:NERV) gained 47.8% to settle at $4.59 after the company announced it submitted a New Drug Application to the FDA for roluperidone for the treatment of patients with schizophrenia.
- Wag! Group Co. (NASDAQ:PET) jumped 47% to close at $7.63 after jumping around 9% on Friday. DA Davidson maintained buy on Wag Group and lowered price target to $11.
- Bon Natural Life Limited (NASDAQ:BON) gained 36.5% to settle at $2.77.
- Signify Health, Inc. (NYSE:SGFY) shares jumped 32.1% to close at $28.00 following media reports that Amazon.com Inc (NASDAQ:AMZN) may be interested in acquiring the company.
- Blue Apron Holdings, Inc. (NYSE:APRN) gained 26.3% to settle at $6.14.
- Graphex Group Limited (NYSE:GRFX) gained 25.2% to close at $3.13 after gaining 21% on Friday. Graphex Technologies, a wholly owned U.S. subsidiary of Graphex Group Limited, highlighted U.S. expansion progress and outlined business strategy.
- Belite Bio, Inc (NASDAQ:BLTE) jumped 22% to close at $26.84. Belite Bio initiated enrollment for the U.S. Phase 3 clinical trial of its lead asset LBS-008 in patients with Stargardt Disease (STGD1), a progressively blinding disease with no approved treatment.
- ZIVO Bioscience, Inc. (NASDAQ:ZIVO) gained 17.3% to settle at $4.44.
- China Automotive Systems, Inc. (NASDAQ:CAAS) rose 16.8% to close at $4.03. China Automotive Systems recently reported second-quarter FY22 sales growth of 5.5% year-on-year to $127.16 million, beating the consensus of $104.39 million.
- Neptune Wellness Solutions Inc. (NASDAQ:NEPT) gained 16.3% to close at $2.00. Neptune Wellness tweeted ‘Sprout secured several distribution gains with leading retailers, including Target, Walmart, and major supermarket chains. And the largest national pharmacy chain in the United States in 5,000 of their 9,900 doors.’
- Reunion Neuroscience Inc. (NASDAQ:REUN) jumped 15.7% to settle at $4.20.
- Greenbrook TMS Inc. (NASDAQ:GBNH) gained 15.6% to close at $3.55 after jumping around 30% on Friday.
- Cano Health, Inc. (NYSE:CANO) jumped 15.2% to close at $5.55 as traders are circulating Dealreporter chatter.
- Privia Health Group, Inc. (NASDAQ:PRVA) rose 15.1% to close at $41.98. Privia Health recently said Q2 EPS results were higher year over year.
- Saga Communications, Inc. (NASDAQ:SGA) gained 14.2% to close at $28.11.
- Houston American Energy Corp. (NASDAQ:HUSA) rose 13.7% to settle at $4.39.
- Mill City Ventures III, Ltd. (NASDAQ:MCVT) gained 13.6% to close at $3.67.
- NightHawk Biosciences, Inc. (NASDAQ:NHWK) climbed 11.9% to close at $2.54 after the company said it would fund development of a monkeypox vaccine.
- Kiromic BioPharma, Inc. (NASDAQ:KRBP) shares gained 11.4% to close at $0.4200. Kiromic Biopharma said the company has determined not to pursue, at this time, the contemplated public offering to which the registration statement relates.
- Avaya Holdings Corp. (NYSE:AVYA) rose 10.6% to close at $0.8011.
- Better Therapeutics, Inc. (NASDAQ:BTTX) shares gained 10% to close at $1.76. Better Therapeutics recently reported Q2 R&D expenses of $4.2 million.
- AMTD Digital Inc. (NYSE:HKD) rose 8.8% to close at $185.00.
- FedNat Holding Company (NASDAQ:FNHC) rose 8.2% to close at $0.43. FedNat received Nasdaq notification of non-compliance with listing rule 5250(c)(1).
- Vipshop Holdings Limited (NYSE:VIPS) rose 7.9% to close at $10.78 after Credit Suisse upgraded the stock from Neutral to Outperform and announced a $12 price target. Vipshop, on Friday, reported a second-quarter FY22 revenue decline of 17.1% year-on-year to $3.66 billion, beating the consensus of $3.39 billion.
- SaverOne 2014 Ltd (NASDAQ:SVRE) rose 6.5% to close at $2.96.
